Schedule Identifying Omitted Documents Related to Neoprobe Corporation Replacement Notes and Warrants
Contract Categories:
Business Finance
›
Note Agreements
Summary
This document lists the specific holders and amounts for Neoprobe Corporation's Replacement Series A Convertible Promissory Notes and Replacement Common Stock Purchase Warrants, as referenced in a prior SEC filing. The only differences from the filed forms are the names of the holders and the amounts or shares involved. The parties include Biomedical Value Fund, L.P., Biomedical Offshore Value Fund, Ltd., and David C. Bupp. The schedule details the principal amounts of the notes and the number of shares covered by the warrants for each holder.
EX-10.4 5 v059593_ex10-4.htm
Exhibit 10.4
SCHEDULE IDENTIFYING OMITTED DOCUMENTS
The only particulars in which the (a) Form of Neoprobe Corporation Replacement Series A Convertible Promissory Note and (b) Form of Neoprobe Corporation Replacement Common Stock Purchase Warrant filed with the Current Report on Form 8-K dated December 4, 2006, differ materially from the omitted instruments are the names of the holders of the warrants, the number of shares of common stock for which the warrants are exercisable, the names of the holders of the notes and the principal amounts of the notes, which information is included in the following tables:
(a) Neoprobe Corporation Replacement Series A Convertible Promissory Notes
| HOLDER | PRINCIPAL AMOUNT |
| Biomedical Value Fund, L.P. | $4,400,000 |
| Biomedical Offshore Value Fund, Ltd. | $3,600,000 |
| David C. Bupp | $100,000 |
(b) Neoprobe Corporation Replacement Common Stock Purchase Warrants
| HOLDER | WARRANT SHARES |
| Biomedical Value Fund, L.P. | 5,500,000 |
| Biomedical Offshore Value Fund, Ltd. | 4,500,000 |
| David C. Bupp | 125,000 |
